FASN and metabolic dysfunction-associated steatotic liver disease: FASN is recognized as a master regulator of NAFLD pathogenesis, thus degradation of FASN protein expression or inhibition of FASN enzyme activity can lead to the suppression of hallmark events in NASH (e.g., fatty acid metabolism, fibrogenesis, and lobular inflammation) (20, 21).